📰 Centaur Labs News
Centaur Labs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Centaur Labs. Real-time updates on events, politics, business and more.
January 3, 2024
AI offers an opportunity for firms to build a better business, if they can integrate the novel technology effectively. Here's a checklist of how to do that.
December 27, 2023
The advances in the use of artificial intelligence (AI) in healthcare this year are set to streamline physician workflows and care delivery in 2024.
December 6, 2023
The new service features powerful APIs for interactive AI annotation and training to accelerate the development of medical imaging solutions
November 30, 2023
NVIDIA announced the launch of a cloud service for medical imaging AI to accelerate the development of specialized AI models.
October 9, 2023
The greater Boston area claims a number of savvy, if under-the-radar, investors as residents. We asked VCs about the ones to know.
October 5, 2023
A free yet challenging approach to teaching medical diagnosis skills with real patients' X-rays and ultrasound images. Among the app's primary users are medical students, nurses, lab technicians, and physicians.
August 15, 2023
/PRNewswire/ -- Lucem Health™, a leading provider of transformational clinical AI solutions, announced today that its Innovation Collaborative doubled the...
July 10, 2023
MIT alumnus’ platform taps the wisdom of crowds to label medical data for AI companies. Centaur Labs created an app that experts use to classify medical data in exchange for small cash prizes. Those opinions are used to train and improve life-saving AI models. When Erik Duhaime PhD ’19 was wor
June 28, 2023
Centaur Labs, founded by MIT alumnus Erik Duhaime, is gamifying medical data labeling with an app called DiagnosUs, which challenges medical professionals to label data for small cash prizes, to advance AI.
May 25, 2023
Those who had had inflammatory bowel disease for less than 5 years and those taking adalimumab, as opposed to another TNFi, had higher likelihood of reaching axial spondyloarthritis remission.